HomeTagsHealth

health

SGX-LISTED COMPANIES

Camsing Healthcare Faces Severe Going Concern Risks As Q2 FY2027 Deficit Deepens

Camsing Healthcare Survival Strategy and the Massive Share Dilution Investors Need to Understand Camsing Healthcare...
AI

Standard Chartered targets AI scale across 50+ markets to smoothen banking friction

Standard Chartered is prioritising client-focused artificial intelligence initiatives that can be scaled across its...
spot_img
SGX-LISTED COMPANIES

Tianjin Pharmaceutical Da Ren Tang Is Shrinking To Succeed In FY2025

How TJ DRT’s 33% Revenue "Loss" Fueled a 72% Margin Miracle and a Record...
SGX-LISTED COMPANIES

The Strategy Keeping Camsing Healthcare Alive – FY2026

The Survival Pivot: 4 Lessons from a Retail Healthcare Turnaround Introduction: The narrative of the legacy...
SGX-LISTED COMPANIES

Why China Medical Systems FY2025 Profits Dropped Despite Growth

https://open.spotify.com/episode/3YAldvdzS4eXE4RzkN9M18?si=8a54594510534cfe 5 Game-Changing Takeaways from CMS’s 2025 Transformation For the Chinese pharmaceutical sector, 2025 was the...
SGX-LISTED COMPANIES

How Raffles Medical Is Trading Episodic Care For Longevity Science In FY2025

Introduction: A Half-Century of Evolution As Raffles Medical Group (RMG) marks its 50th anniversary, it...
SGX-LISTED COMPANIES

iX Biopharma’s Secret Shortcut To The US Medical Market – 1H FY2026

From Cash Burn to Bioavailability: How iX Biopharma Slashed Losses by 67% via a...
SGX-LISTED COMPANIES

From Superfoods To Senior Care – Autagco Q1 FY2026

The High-Stakes Gamble of a Singapore Mainstay Introduction: The "Pivot or Perish" Reality In the unforgiving...
SGX-LISTED COMPANIES

Is Camsing Healthcare In Survival Mode? The Truth Behind Their Q3 FY2026

On the Brink of Collapse: 3 Surprising Truths Buried in Camsing Healthcare's Latest Report 1....
SGX-LISTED COMPANIES

One Asset Deal Changed Everything For Tianjin Da Ren Tang In Q3 2025

How Tianjin Da Ren Tang's Revenue Fell 35% While Its Profits Soared: 4 Surprising...
SGX-LISTED COMPANIES

Singapore Paincare Swings To Net Loss In FY2025

5 Surprising Reasons Behind Singapore Paincare's Shocking Swing from Profit to a S$3.7 Million...
SGX-LISTED COMPANIES

Find Out Why ISEC Healthcare’s Strong Q3 2025 Sales Didn’t Translate To Higher Profits

More Sales, Less Profit: 5 Surprising Takeaways from ISEC Healthcare's Latest Financials It’s a fundamental...
SGX-LISTED COMPANIES

Camsing Healthcare Second Quarter 2026 Results

Camsing Healthcare Limited's latest financial results show a mixed performance amid tough economic conditions....
SGX-LISTED COMPANIES

Thomson Medical Group’s FY2025: Strategic Growth and Johor Bay Development

Thomson Medical Group's recent financial period reflects a deliberate investment strategy for future growth,...
Load more

Latest articles

SGX-LISTED COMPANIES

Camsing Healthcare Faces Severe Going Concern Risks As Q2 FY2027 Deficit Deepens

Camsing Healthcare Survival Strategy and the Massive Share Dilution Investors Need to Understand Camsing Healthcare...
AI

Standard Chartered targets AI scale across 50+ markets to smoothen banking friction

Standard Chartered is prioritising client-focused artificial intelligence initiatives that can be scaled across its...
SGX-LISTED COMPANIES

All-Link Air & Sea’s 1H FY2026 Revenue Surges But One-Off IPO Costs Hit Bottom Line

All Link Numbers Show Growth Beyond the IPO Noise All-Link Air & Sea Limited has...
SGX-LISTED COMPANIES

Singapore Construction Boom Drives Reclaims Global 1H FY2027

The Strategic Asset Pivot Powering Reclaims Global Massive Growth Streak The Singapore construction sector is...